Status:
COMPLETED
COVID-19 Seroprevalence Study in ITM Staff
Lead Sponsor:
Institute of Tropical Medicine, Belgium
Conditions:
Covid19
Eligibility:
All Genders
Brief Summary
In Belgium, the corona virus disease 2019 (COVID-19) epidemic is in the growing phase of its second wave. The Belgian crisis cell is balancing between allowing the economy to recover and minimize the...
Detailed Description
The study is observational and will be conducted on ITM staff members. All members will be invited to participate.
Eligibility Criteria
Inclusion
- Be an active ITM staff member
- Be willing and able to complete the questionnaire
- Be willing and able to provide informed consent
Exclusion
- Doctor of Philosophy (PhD) students, Master students and interns of the ITM
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 9 2020
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT04503447
Start Date
August 1 2020
End Date
September 9 2020
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Tropical Medicine
Antwerp, Belgium, 2000